A Study of Dapansutrile Plus Pembrolizumab in Patients with PD-1 Refractory Advanced Melanoma

Clinical Trial Grant

Duke Scholars

Principal Investigator April Kelly Scott Salama Medicine, Medical Oncology

Awarded By

Olatec Therapeutics LLC

Start Date

August 10, 2022

End Date

August 14, 2027

Awarded By

Olatec Therapeutics LLC

Start Date

August 10, 2022

End Date

August 14, 2027